This could make quitting easier for many people
Contact your GP promptly if you experience: Symptoms of hyperthyroidism (rapid heartbeat, tremor, anxiety, weight loss) or worsening hypothyroidism symptoms (fatigue, weight gain, cold intolerance) Severe or persistent gastrointestinal symptoms Signs of hypoglycaemia, particularly if taking other diabetes medications such as sulfonylureas or insulin (which may require dose reduction when starting Rybelsus) Severe abdominal pain (potential pancreatitis) Visual changes (potential diabetic retinopathy progression) Dehydration due to gastrointestinal side effects, which could affect kidney function Never adjust doses of either medication independently
The reason this question gets asked so often is that a large share of GLP-1 patch advertising is built around female-coded weight-loss anxiety: hormonal belly fat, metabolic slowdown after 40, stubborn weight that "diet and exercise won't touch." Those frustrations are real and often physiologically grounded
In the published Mounjaro trials, roughly 25-30% of total weight loss is from lean mass, including muscle
They come in three common sizes